This site is only for patients in the United Kingdom who have been prescribed CAMZYOS®▼ (mavacamten)

This site is only for patients in the United Kingdom who have been prescribed CAMZYOS®▼ (mavacamten)

Menu
FAQs
FAQs
FAQs
FAQs
FAQs
image

CAMZYOS resources

This section of the website is currently undergoing maintenance

We are working to resolve this as soon as possible. Please check back shortly

EMC, Electronic Medicines Compendium; HCM, hypertrophic cardiomyopathy.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See http://www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com.

 

 

Legal Notice    |    Privacy Policy

© 2024 MyoKardia, Inc., a Bristol-Myers Squibb company. All rights reserved.

3500-GB-2400445  |  November 2024